Joseph H. Friedman Source Confirmed

OverviewAI-generated summary

Joseph H. Friedman is an active researcher focusing on neurological and metabolic disorders, with a particular emphasis on Parkinson's Disease and Schizophrenia. His work spans both mechanistic studies and clinical treatments, including investigations into electroconvulsive therapy. Recent publications have addressed the effect of urate-elevating inosine on early Parkinson's disease progression, the underuse of clozapine in Parkinson's patients, and the efficacy of amantadine in treating levodopa-induced dyskinesia. Friedman's research also explores innovative therapeutic approaches, such as recovery incentive programs and oculomotor tests in vestibular rehabilitation for Parkinson's patients. He is currently a Program Director at John Brown University.

Metrics

• h-index: 79
• Publications: 2161
• Citations: 21,843